Anti-CD4 antibody treatment of patients with rheumatoid arthritis: I. Effect on clinical course and circulating T cells (Q40770881)

23 September 2017

title

Anti-CD4 antibody treatment of patients with rheumatoid arthritis: I. Effect on clinical course and circulating T cells (English)

1 reference

23 September 2017

1 reference

Herzog C

1

1 reference

23 September 2017

Walker C

2

1 reference

23 September 2017

Müller W

3

1 reference

23 September 2017

Rieber P

4

1 reference

23 September 2017

Reiter C

5

1 reference

23 September 2017

Riethmüller G

6

1 reference

23 September 2017

Wassmer P

7

1 reference

23 September 2017

Stockinger H

8

1 reference

23 September 2017

Madic O

9

1 reference

23 September 2017

Pichler WJ

10

1 reference

23 September 2017

publication date

1 October 1989

1 reference

23 September 2017

published in

Journal of Autoimmunity

1 reference

23 September 2017

volume

2

1 reference

23 September 2017

issue

5

1 reference

23 September 2017

page(s)

627-642

1 reference

NIH conference. Rheumatoid arthritis: evolving concepts of pathogenesis and treatment

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2889%2980002-2

7 January 2021

T lymphocytes in blood and synovial fluid in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2889%2980002-2

7 January 2021

T cytotoxic and helper cells are markedly increased, and T suppressor and inducer cells are markedly decreased, in rheumatoid synovial fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2889%2980002-2

7 January 2021

Clinical and immunologic effects of fractionated total lymphoid irradiation in refractory rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2889%2980002-2

7 January 2021

Treatment of intractable rheumatoid arthritis with total lymphoid irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2889%2980002-2

7 January 2021

Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2889%2980002-2

7 January 2021

Treatment of acute renal allograft rejection with monoclonal anti-T12 antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2889%2980002-2

7 January 2021

A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2889%2980002-2

7 January 2021

Immunologic responses of progressive multiple sclerosis patients treated with an anti-T-cell monoclonal antibody, anti-T12.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2889%2980002-2

7 January 2021

In vivo effects of antibodies to immune response gene products: prevention of experimental allergic encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2889%2980002-2

7 January 2021

Treatment of (NZB x NZW)F1 disease with anti-I-A monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2889%2980002-2

7 January 2021

Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2889%2980002-2

7 January 2021

Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T-cell subset marker

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2889%2980002-2

7 January 2021

Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2889%2980002-2

7 January 2021

The mechanism of inhibition of experimental allergic encephalomyelitis in the rat by monoclonal antibody against CD4.

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2889%2980002-2

7 January 2021

Induction of tolerance by monoclonal antibody therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2889%2980002-2

7 January 2021

Therapeutic criteria in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2889%2980002-2

7 January 2021

Epitopes of the CD4 antigen and HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2889%2980002-2

7 January 2021

Preliminary criteria for clinical remission in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2889%2980002-2

7 January 2021

Anti-CD4 antibody treatment of patients with rheumatoid arthritis: II. Effect of in vivo treatment on in vitro proliferative response of CD4 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2889%2980002-2

7 January 2021

The differentiation and function of human T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2889%2980002-2

7 January 2021

T Cell Subsets and the Recognition of MHC Class

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2889%2980002-2

7 January 2021

Clonal analysis of human cytotoxic T lymphocytes: T4+ and T8+ effector T cells recognize products of different major histocompatibility complex regions

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2889%2980002-2

7 January 2021

Perturbation of the T4 molecule transmits a negative signal to T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2889%2980002-2

7 January 2021

Lymphapheresis in rheumatoid arthritis. A randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2889%2980002-2

7 January 2021

Deficiency of the suppressor inducer subset of T lymphocytes in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2889%2980002-2

7 January 2021

Idiotype switching of CD4-specific monoclonal antibodies can prolong the therapeutic effectiveness in spite of host anti-mouse IgG antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0896-8411%2889%2980002-2

7 January 2021

10.1016/S0896-8411(89)80002-2

Identifiers

DOI

1 reference

release_fgtem4fzeffpzf72la62mw4vka

23 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fgtem4fzeffpzf72la62mw4vka

24 November 2022

mapped directly with Wikidata item

1 reference